Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review

People with multiple sclerosis (MS) face challenges adhering to disease-modifying drug (DMD) treatment. Poor adherence to treatment reduces its clinical effectiveness which can adversely impact disease progression, MS-related hospitalisation, and mortality rates. Understanding the barriers to adhere...

Descripción completa

Detalles Bibliográficos
Autores principales: Washington, Francesca, Langdon, Dawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940867/
https://www.ncbi.nlm.nih.gov/pubmed/34676448
http://dx.doi.org/10.1007/s00415-021-10850-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940867/
https://www.ncbi.nlm.nih.gov/pubmed/34676448
http://dx.doi.org/10.1007/s00415-021-10850-w

Ejemplares similares